Acitretin mitigates uroporphyrin-induced bone defects in congenital erythropoietic porphyria models
Abstract Congenital erythropoietic porphyria (CEP) is a rare genetic disorder leading to accumulation of uro/coproporphyrin-I in tissues due to inhibition of uroporphyrinogen-III synthase. Clinical manifestations of CEP include bone fragility, severe photosensitivity and photomutilation. Currently t...
Saved in:
Main Authors: | Juliana Bragazzi Cunha, Jared S. Elenbaas, Dhiman Maitra, Ning Kuo, Rodrigo Azuero-Dajud, Allison C. Ferguson, Megan S. Griffin, Stephen I. Lentz, Jordan A. Shavit, M. Bishr Omary |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/e06a443978e94eb7b7e1577a00409af2 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An Atypical Case of Congenital Erythropoietic Porphyria
by: Bénédicte Sudrié-Arnaud, et al.
Published: (2021) -
Acute porphyrias – A neurological perspective
by: Lea M. Gerischer, et al.
Published: (2021) -
Improvement in ocular cicatricial pemphigoid following treatment for porphyria cutanea tarda
by: Ford RM, et al.
Published: (2012) -
The severity of hereditary porphyria is modulated by the porphyrin exporter and Lan antigen ABCB6
by: Yu Fukuda, et al.
Published: (2016) -
Acute intermittent porphyria caused by novel mutation in HMBS gene, misdiagnosed as cholecystitis
by: Alfadhel M, et al.
Published: (2014)